Am J Transplant, Volume 21, Suppl 3 Archives - ATC Abstracts

2021 American Transplant Congress
Clinical Consequences in Patients Experiencing Leukopenia and Neutropenia After Solid Organ Transplant
A. Diamond¹, N. Diehl², K. Hiryak³, K. Mortia¹, J. Au¹, C. Ruggia-Check¹, H. Clauss⁴
¹Pharmacy, Temple University Hospital, Philadelphia, PA, ²Pharmacy, UPMC Pinnacle Health, Harrisburg, PA, ³Pharmacy, Temple University School of Pharmacy, Philadelphia, PA, ⁴Infectious Diseases, Temple University Hospital, Philadelphia, PA
*Purpose: The incidence of leukopenia and neutropenia in solid organ transplant (SOT) recipients can be influenced by medications required after transplant for immunosuppression and infection…
2021 American Transplant Congress
Immune Response to Covid-19 in Kidney Transplant Waitlist Patients
P. T. Jindra¹, C. M. Foye¹, I. Sharf², A. Rana¹, T. N. Galvan¹, A. Awan¹, C. A. O'Mahony¹, B. V. Murthy¹
¹Baylor College of Medicine, Houston, TX, ²Baylor St. Luke's Medical Center, Houston, TX
*Purpose: The purpose of this study was to determine the effect of SARS-CoV-2 infection on the immune response in Kidney Transplant Waitlist Candidates (KTWC) and…
2021 American Transplant Congress
Clinical Outcomes of Culture-Positive Pneumonia in Solid Organ Transplant Recipients
L. Rice¹, A. C. Kalil², D. Hixson², M. Leick³
¹Monument Health, Rapid City, SD, ²University of Nebraska Medical Center, Omaha, NE, ³Nebraska Medicine, Omaha, NE
*Purpose: The purpose of this study is to determine the differences in clinical outcomes of culture-positive pneumonia in solid organ transplant (SOT) recipients compared to…
2021 American Transplant Congress
Risk Factors of COVID-19 in Kidney Transplant Recipients
M. M. Alkadi, E. Abuhelaiqa, M. Asim, O. Fituri, R. Elidrisi, R. Abdul Rahiman, M. Elshirbeny, M. Othman, A. Hamad, A. Ashour, A. Hamdi, A. Nauman, H. Tohid, M. Jarman, H. Al-Malki
Nephrology-Medicine, Hamad Medical Corporation, Doha, Qatar
*Purpose: Kidney transplant recipients have been shown to develop a severe form of coronavirus disease (COVID-19) that poses a significant mortality risk. The aim of…
2021 American Transplant Congress
Impact of Belatacept and Tacrolimus on Cmv Viral Load Control and Relapse in Moderate and High-risk Cmv Serostatus Kidney Transplant Recipients
W. Magua¹, A. C. Johnson¹, G. M. Karadkhele¹, I. R. Badell¹, P. Vasanth¹, M. G. Lyon III², A. K. Mehta², K. A. Easley³, J. Rickert⁴, C. P. Larsen¹
¹Department of Surgery, Emory University, Atlanta, GA, ²Department of Medicine, Emory University, Atlanta, GA, ³Biostatistics and Bioinformatics, Emory University, Atlanta, GA, ⁴RStudio and R Consortium, San Jose, CA
*Purpose: We aim to evaluate the impact of belatacept and tacrolimus on CMV viral load control, remission and relapse in CMV high-risk (serostatus, D+/R-) and…
2021 American Transplant Congress
Significance of Detectable but Unquantifiable Viremias Post Renal Transplantation
M. Chaung, S. Puri, S. Bunin, Z. Mondal, O. Eletta, R. Pelletier, A. Bongu
Robert Wood Johnson University Hospital, New Brunswick, NJ
*Purpose: It is unknown whether the degree of the initial viremia following kidney (KT) or combined kidney-pancreas transplantation (SPKT) correlates with future allograft rejection or…
2021 American Transplant Congress
Outcomes of Deceased Donor Transplants with Donor Specific Antibodies Before and After the New Kidney Allocation System
R. Crew, P. Khairallah, S. S. Patel
Columbia University, New York, NY
*Purpose: KAS forced centers to list unacceptable HLA antigens. Some centers excluded antigens at any level of anti-HLA Ab. Our center only excluded antibodies posing…
2021 American Transplant Congress
Outcomes in Highly Sensitized Kidney Transplant Recipients Receiving DCD Organs
A. Diamond¹, L. Rodrigues², A. Di Carlo³, S. Karhadkar³
¹Pharmacy, Temple University Hospital, Philadelphia, PA, ²Temple University, Philadelphia, PA, ³Surgery, Temple University Hospital, Philadelphia, PA
*Purpose: Highly sensitized (HS) patients experience longer wait times for kidney transplantation despite prioritization by the Kidney Allocation System. Kidney transplants performed from donors defined…
2021 American Transplant Congress
Efficacy of Hope: Analysis of Quality HIV+ Deceased Donor Organ Availability
G. E. Owens¹, B. Shelton¹, P. MacLennan¹, D. Sawinski², J. E. Locke¹
¹Transplant, University of Alabama at Birmingham, Birmingham, AL, ²Transplant, University of Pennsylvania, Philadeplphia, PA
*Purpose: The purpose of this study is to understand the number of organs actually available for HIV+ to HIV+ transplant utilizing data on a national…
2021 American Transplant Congress
The Impact of Health Literacy on Kidney Transplant Listing
G. Chen¹, J. Siahaan², L. Leon Novelo², I. Rizvi³, A. M. De Golovine⁴, A. R. Edwards⁴, A. Pai⁴, W. A. Dar³
¹Abdominal Transplant, Memorial Hermann Hospital, Houston, TX, ²Department of Biostatistics and Data Science, School of Public Health The University of Texas Health Science Center at Houston, Houston, TX, ³Department of Surgery, McGovern Medical School The University of Texas Health Science Center at Houston, Houston, TX, ⁴Department of Internal Medicine, Renal Diseases and Hypertension, McGovern Medical School The University of Texas Health Science Center at Houston, Houston, TX
*Purpose: Limited health literacy has long been associated with poor health outcomes in the general population, but there have been few studies investigating the association…

1
2
3
…
139
Next Page »